HITS

HITS develops artificial intelligence software for drug discovery and pharmaceutical research.

AI agentsHealth and bio

HITS has no funding amount on record yet; its latest known round is Series B+ (Sep 2026). Recent Funding first saw it on October 4, 2026.

Founders and team

• JL
  Jaechang Lim Founder

  source: crunchbase.com
• WY
  Woo Youn Kim Founder

  source: crunchbase.com

Raise history

1. September 28, 2026
   Series B+ · amount undisclosed
   KKorea Investment Partners, PPremier Partners, YYuanta Investment
   Source: biz.chosun.com

Investors

• CCapstone Partners
• GGoogle DeepMind
• KKiwoom Investment
• KKorea Investment Partners
• LLaplace Partners
• PPremier Partners
• SStick Ventures
• YYuanta Investment

Related ai companies

• AAI Diagnostics$5M · Oct 2, 2026
• GGood Tape$600K · Oct 2, 2026
• AArmadin$255M · Oct 2, 2026
• OOsavul$8.5M · Oct 1, 2026
• PParakeet Health$10M · Oct 1, 2026
• VVeyloOct 1, 2026
• OOptimizeGEO.aiOct 1, 2026
• 11club AI$2.49M · Oct 1, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/hits.